抗体药物偶联物治疗恶性肿瘤临床应用 中国专家共识（2023 版）.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 741, doi. 10.3760/cma.j.cn112152-20220713-00489
- By:
- Publication type:
- Article
Works matching IS 02533766 AND DT 2023 AND VI 45 AND IP 9
Results: 7
1
2
DNA 损伤修复变异与三阴性乳腺癌辅助 治疗的相关性研究.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 787, doi. 10.3760/ema.j.cn112152-20220912-00612
- By:
- Publication type:
- Article
3
下调溶质运载体家族7成员11对表皮生长 因子受体基因 19 号外显子突变肺腺癌细胞 吉非替尼耐药性的影响及其机制.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 779, doi. 10.3760/cma.j.cn112152-20220715-00493
- By:
- Publication type:
- Article
4
江苏省启东市鼻咽癌生存率长期趋势分析.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 773, doi. 10.3760/cma.j.cn112152-20220823-00575
- By:
- Publication type:
- Article
5
基于实时荧光定量ＰＣＲ技术的肿瘤分子 病理检测临床实践中国专家共识（2023 版）.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 763, doi. 10.3760/cma.j.cn112152-20221231-00868
- By:
- Publication type:
- Article
6
基于罕见家系探讨遗传咨询与预防性手术 在遗传性乳腺癌⁃卵巢癌综合征中的实施 要点.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 796, doi. 10.3760/cma.j.cn112152-20211108-00825
- By:
- Publication type:
- Article
7
驱动基因阳性晚期非小细胞肺癌免疫治疗 专家共识（2023 版）.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 717, doi. 10.3760/cma.j.cn112152-20230420-00179
- By:
- Publication type:
- Article